Click to copy
Click to copy

Trillium: 2Q Earnings Snapshot

August 13, 2019

MISSISSAUGA, Ontario (AP) _ Trillium Therapeutics Inc. (TRIL) on Tuesday reported a loss of $4.9 million in its second quarter.

On a per-share basis, the Mississauga, Ontario-based company said it had a loss of 18 cents.

The developer of immune therapies that target cancer posted revenue of $25,400 in the period. Its adjusted revenue was $25,000.

The company’s shares closed at 31 cents. A year ago, they were trading at $5.50.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TRIL at https://www.zacks.com/ap/TRIL

All contents © copyright 2019 The Associated Press. All rights reserved.